Janus Henderson Group
CRDF icon

Janus Henderson Group’s Cardiff Oncology CRDF Stock Holding History

Janus Henderson Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,742,123
Closed -$4.32M – 2613
2022
Q1 		$4.32M Sell
1,742,123
-1,780,889
-51% -$6.3M ﹤0.01% 1042
2021
Q4 		$21.2M Sell
3,523,012
-10,369
-0.3% -$61.8K 0.01% 772
2021
Q3 		$23.5M Buy
3,533,381
+382,214
+12% +$2.4M 0.01% 754
2021
Q2 		$21M Buy
3,151,167
+213,985
+7% +$1.81M 0.01% 777
2021
Q1 		$27.2M Buy
2,937,182
+799,511
+37% +$9.71M 0.01% 703
2020
Q4 		$38.4M Buy
2,137,671
+1,124,853
+111% +$19.8M 0.02% 603
2020
Q3 		$14.4M Buy
+1,012,818
New +$6.69M 0.01% 770

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return